Received Mar 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | IM |
minor side effects/minor soreness at the injection site; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (minor side effects/minor soreness at the injection site) in a male patient of an unknown age who received mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) for COVID-19 prophylaxis. No Medical History information was reported. In 2024, the patient received dose of mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (minor side effects/minor soreness at the injection site). At the time of the report, VACCINATION SITE PAIN (minor side effects/minor soreness at the injection site) had resolved. The concomitant medication was not reported by reporter. Patient had all of the COVID vaccinations and all of the COVID vaccinations he had were Moderna vaccinations and he was satisfied with the outcome and the side effects. It was unknown if the patient experienced any additional symptoms/events. The treatment medication was not reported by reporter. This case was linked to US-MODERNATX, INC.-MOD-2025-783399 (E2B Linked Report). Reporter did not allow further contact; Sender's Comments: US-MODERNATX, INC.-MOD-2025-783399:Same patient but different product